Lalaine Anova, MS

Lalaine
Anova
Manager, Research Programs
Division of Infectious Diseases
l.anova@vumc.org

Dr. Dooley’s TB research receives MERIT Award from the NIH

Kelly Dooley, MD, PhD, MPH, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases at Vanderbilt University Medical Center, has received a MERIT Award (Method to Extend Research in Time Award) from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Kristin L. Patrick, Ph.D.

Kristin
L.
Patrick
Ph.D.
Associate Professor
Department of Pathology, Microbiology, Immunology
kristin.patrick@vumc.org

VTC to lead a $2.3 million study on subclinical TB

The Vanderbilt TB Center will lead a two-year, $2.3 million project funded by CRDF Global, to conduct research on the prevalence and incidence of subclinical tuberculosis(TB) in close contacts and evaluate novel biomarkers and diagnostic tests for subclinical TB. The true prevalence and incidence of subclinical TB in close TB contacts is unclear, and the optimal diagnostic method for subclinical TB is unknown.

NIH Awards UM1 Funding to Establish PReDicTR Consortium

Rada Savic, PhD and colleagues Eric Nuermberger, MD (JHU), Kelly Dooley, MD, PhD, MPH (Vanderbilt), and Dirk Schnappinger, PhD (WCM) have been awarded a five-year $30.8M, UM1 cooperative agreement award from NIAID/NIH to establish a consortium of tuberculosis preclinical and clinical experts to research the most effective treatment options for future clinical testing, called the Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium. PReDicTR will establish a mu

Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional), Expires: December 05, 2024

Open Date (Earliest Submission Date): November 04, 2024Expiration Date: December 05, 2024Funds Available and Anticipated Number of AwardsNIAID intends to commit $6,000,000 in FY 2025 to fund 4-5 awards.Award BudgetApplication budgets are not expected to exceed $750,000 in direct costs per year, and should reflect the actual needs of the project. Award Project PeriodThe scope of the proposed project should determine the project period. The maximum project period is 5 years.

VTC Hosts LTBI R01 Meeting

The Vanderbilt Tuberculosis Center recently hosted a meeting of researchers involved in our LTBI R01 project “Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts” (NIH R01AI147765). The event, which took place between March 21st and 22nd, and included presentations about ongoing research and data findings, working group sessions, and breakout meetings.